Literature DB >> 8567967

Hyperproinsulinemia is associated with increased beta cell demand after hemipancreatectomy in humans.

E R Seaquist1, S E Kahn, P M Clark, C N Hales, D Porte, R P Robertson.   

Abstract

The cause of disproportionate hyperproinsulinemia in patients with type II diabetes is controversial. To examine whether increased beta cell demand might contribute, we measured proinsulin and insulin concentrations in clinically healthy humans who had undergone hemipancreatectomy for the purpose of organ donation, a procedure previously demonstrated to increase beta cell demand and diminish insulin secretory reserve capacity. Subjects were studied at least 1 yr after hemipancreatectomy. Seven donors were followed prospectively and serves as their own controls. Nine additional donors were matched with normal controls (cross-sectional group). Fasting serum concentrations of intact proinsulin and conversion intermediates (total) were measured by a two-step radioimmunoassay; independent determinations of intact proinsulin and 32,33 split proinsulin were performed using an immunoradiometric assay. Serum total proinsulin values were significantly greater in hemipancreatectomized groups than controls (prospective group: predonation = 6.24 +/- 1.14 pM, postdonation = 34.63 +/- 17.47 pM, P < 0.005; cross-sectional group: controls = 5.78 +/- 1.12 pM, donors = 15.22 +/- 5.20 pM, P < 0.025). The ratio of total proinsulin to immunoreactive insulin was directly correlated with fasting plasma glucose and showed a significant inverse relationship to secretory reserve capacity. Both absolute and relative hyperproinsulinemia is found in hemipancreatectomized donors. These data demonstrate that partial pancreatectomy with its associated increase in beta cell demand raises measures of proinsulin in humans.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8567967      PMCID: PMC507037          DOI: 10.1172/JCI118435

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  Raised proinsulin concentration as early indicator of beta cell dysfunction.

Authors:  D R Williams; C Byrne; P M Clark; L Cox; N E Day; G Rayman; T Wang; C N Hales
Journal:  BMJ       Date:  1991-07-13

2.  Glucose-induced insulin response is reduced and proinsulin response increased in healthy siblings of type 1 diabetic patients.

Authors:  F A Lindgren; S G Hartling; G G Dahlquist; C Binder; S Efendić; B E Persson
Journal:  Diabet Med       Date:  1991 Aug-Sep       Impact factor: 4.359

3.  Inhibition of ATP-sensitive K+ channels in pancreatic beta-cells by nonsulfonylurea drug linogliride.

Authors:  P Ronner; T J Higgins; G A Kimmich
Journal:  Diabetes       Date:  1991-07       Impact factor: 9.461

4.  Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans.

Authors:  D M Kendall; D E Sutherland; J S Najarian; F C Goetz; R P Robertson
Journal:  N Engl J Med       Date:  1990-03-29       Impact factor: 91.245

5.  Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus.

Authors:  M F Saad; S E Kahn; R G Nelson; D J Pettitt; W C Knowler; M W Schwartz; S Kowalyk; P H Bennett; D Porte
Journal:  J Clin Endocrinol Metab       Date:  1990-05       Impact factor: 5.958

6.  Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins.

Authors:  W J Sobey; S F Beer; C A Carrington; P M Clark; B H Frank; I P Gray; S D Luzio; D R Owens; A E Schneider; K Siddle
Journal:  Biochem J       Date:  1989-06-01       Impact factor: 3.857

7.  Hyperinsulinaemia in obesity is not accompanied by an increase in serum proinsulin/insulin ratio in groups of human subjects with and without glucose intolerance.

Authors:  I Shiraishi; Y Iwamoto; T Kuzuya; A Matsuda; S Kumakura
Journal:  Diabetologia       Date:  1991-10       Impact factor: 10.122

Review 8.  Hyperproinsulinemia and amyloid in NIDDM. Clues to etiology of islet beta-cell dysfunction?

Authors:  D Porte; S E Kahn
Journal:  Diabetes       Date:  1989-11       Impact factor: 9.461

Review 9.  Banting lecture 1990. Beta-cells in type II diabetes mellitus.

Authors:  D Porte
Journal:  Diabetes       Date:  1991-02       Impact factor: 9.461

10.  Increased beta-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance.

Authors:  S E Kahn; J C Beard; M W Schwartz; W K Ward; H L Ding; R N Bergman; G J Taborsky; D Porte
Journal:  Diabetes       Date:  1989-05       Impact factor: 9.461

View more
  19 in total

1.  Kalirin/Trio Rho GDP/GTP exchange factors regulate proinsulin and insulin secretion.

Authors:  Quinn Dufurrena; Nils Bäck; Richard E Mains; Louis Hodgson; Herbert Tanowitz; Prashant Mandela; Elizabeth Eipper; Regina Kuliawat
Journal:  J Mol Endocrinol       Date:  2018-11-01       Impact factor: 5.098

Review 2.  Lessons learned from more than 1,000 pancreas transplants at a single institution.

Authors:  D E Sutherland; R W Gruessner; D L Dunn; A J Matas; A Humar; R Kandaswamy; S M Mauer; W R Kennedy; F C Goetz; R P Robertson; A C Gruessner; J S Najarian
Journal:  Ann Surg       Date:  2001-04       Impact factor: 12.969

3.  Exposure of human islets to cytokines can result in disproportionately elevated proinsulin release.

Authors:  K Hostens; D Pavlovic; Y Zambre; Z Ling; C Van Schravendijk; D L Eizirik; D G Pipeleers
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

4.  Intracellular amyloid-like deposits contain unprocessed pro-islet amyloid polypeptide (proIAPP) in beta cells of transgenic mice overexpressing the gene for human IAPP and transplanted human islets.

Authors:  J F Paulsson; A Andersson; P Westermark; G T Westermark
Journal:  Diabetologia       Date:  2006-03-29       Impact factor: 10.122

5.  Elevated Intact Proinsulin Levels During an Oral Glucose Challenge Indicate Progressive ß-Cell Dysfunction and May Be Predictive for Development of Type 2 Diabetes.

Authors:  Andreas Pfützner; Iris Hermanns; Sanja Ramljak; Filiz Demircik; Anke H Pfützner; Peter H Kann; Matthias M Weber
Journal:  J Diabetes Sci Technol       Date:  2015-09-29

6.  Effects of mitiglinide, a short-acting insulin secretagogue, on daily glycemic variability and oxidative stress markers in Japanese patients with type 2 diabetes mellitus.

Authors:  Noriko Kodani; Yoshifumi Saisho; Kumiko Tanaka; Toshihide Kawai; Hiroshi Itoh
Journal:  Clin Drug Investig       Date:  2013-08       Impact factor: 2.859

7.  Effect of glucagon-like peptide-1 on beta- and alpha-cell function in isolated islet and whole pancreas transplant recipients.

Authors:  Michael R Rickels; Rebecca Mueller; James F Markmann; Ali Naji
Journal:  J Clin Endocrinol Metab       Date:  2008-10-28       Impact factor: 5.958

Review 8.  Misfolded proinsulin in the endoplasmic reticulum during development of beta cell failure in diabetes.

Authors:  Anoop Arunagiri; Leena Haataja; Corey N Cunningham; Neha Shrestha; Billy Tsai; Ling Qi; Ming Liu; Peter Arvan
Journal:  Ann N Y Acad Sci       Date:  2018-01-28       Impact factor: 5.691

9.  {beta}-Cell secretory capacity and demand in recipients of islet, pancreas, and kidney transplants.

Authors:  Michael R Rickels; Rebecca Mueller; Karen L Teff; Ali Naji
Journal:  J Clin Endocrinol Metab       Date:  2010-01-22       Impact factor: 5.958

10.  Middle segment pancreatectomy: a useful tool in the management of pancreatic neoplasms.

Authors:  Claudio Bassi
Journal:  J Gastrointest Surg       Date:  2007-06       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.